Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial
- 1 February 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9203) , 517-522
- https://doi.org/10.1016/s0140-6736(99)07391-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B VitaminsCirculation, 1998
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trialsBMJ, 1998
- Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention TrialArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.Stroke, 1994
- Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis, 1994
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976